genzym
skip
content
skip
navig
return
homepag
home
sanofi
genzym
global
genzym
websit
search
contact
compani
info
our
treatment
area
our
product
healthcar
genzym
genzym
dedic
make
posit
impact
live
peopl
seriou
diseas
oper
two
locat
draw
divers
talent
team
more
genzym
uklearn
oper
career
ukexplor
opportun
cultur
newslearn
new
genzym
new
research
develop
pivot
phase
trial
olipudas
alfa
adult
patient
acid
defici
diseas
type
begin
sanofi
genzym
specialti
care
global
busi
unit
sanofi
announc
today
first
adult
patient
enrol
dose
pivot
phase
clinic
trial
name
ascend
investig
therapi
olipudas
alfa
more
data
treatment
effect
over
six
year
peopl
relaps
remit
multipl
sclerosi
present
congress
european
committe
treatment
research
multipl
sclerosi
ectrim
london
sanofi
genzym
specialti
care
global
busi
unit
sanofi
today
announc
sixyear
investig
data
extens
studi
patient
relaps
remit
multipl
sclerosi
rrm
these
result
present
congress
european
committe
treatment
research
multipl
sclerosi
ectrim
london
more
sanofi
regeneron
announc
ema
accept
review
market
authoris
applic
sarilumab
sanofi
regeneron
inc
today
announc
european
medicin
agenc
ema
accept
review
market
authoris
applic
maa
sarilumab
investig
human
monoclon
antibodi
direct
receptor
intend
treatment
adult
patient
moder
sever
activ
arthriti
more
search
keyword
discov
genzym
purpos
legaci
innov
corpor
brochur
privaci
polici
term
condit
use
genzym
sanofi
compani
all
right
reserv
